Nuclera exists to remove uncertainty from protein science. As the pioneer of multiplex protein screening, we help researchers start with clarity, so ideas move faster to result. We believe access to your protein should be a certainty, not a gamble. eProtein Discovery™ is how we deliver on that promise, but our aim is bigger: to make protein access routine for every lab, accelerate breakthroughs in human health, and empower scientists to spend more time on discovery and less on delay. Our eProtein Discovery™ system combines unique cell free expression systems, novel digital microfluidics, and robust screening data, to create an effortlessly multiplex protein screening solution that empowers you to perform your own protein screening, characterization, and small-scale expression in-house within days — even challenging membrane proteins Founded in 2013 by PhD students at the University of Cambridge, the company now has a presence in Cambridge, UK and Boston, MA employing over 100 employees.
Looking for a particular Nuclera employee's phone or email?
The Nuclera annual revenue was $30.3 million in 2026.
Gordon McInroy is the Founder and COO of Nuclera.
107 people are employed at Nuclera.
The NAICS codes for Nuclera are [5417, 541714, 33, 54171, 541, 54, 333].
The SIC codes for Nuclera are [87, 35, 873, 355].